美国脓毒症住院患者中降钙素原及其他生物标志物的实际使用:一项回顾性观察研究
源于美国医院数据库的脓毒症住院患者回顾性观察数据集,包含降钙素原等生物标志物使用、住院费用和死亡率等临床数据。

基本信息
资源简介
美国脓毒症住院患者中降钙素原及其他生物标志物的实际使用:一项回顾性观察研究
【数据集背景】
本数据集源站标题为《Real-world use of procalcitonin and other biomarkers among sepsis hospitalizations in the United States: A retrospective, observational study》。配套论文《Real-world use of procalcitonin and other biomarkers among sepsis hospitalizations in the United States: A retrospective, observational study》发表于 PLOS ONE(2018),DOI:10.1371/journal.pone.0205924。源站首次发布:2018-10-17。
【数据内容】
源站原始描述:Background Sepsis management guidelines endorse use of biomarkers to support clinical assessment and treatment decisions in septic patients. The impact of biomarkers on improving patient outcomes remains uncertain. Methods Retrospective observational study of adult sepsis discharges between January 1, 2012, and December 31, 2015, from Premier Healthcare Database hospitals. Sepsis was defined by an All Patients Refined Diagnosis-Related Group code of 720 (septicemia and disseminated infections).…
【数据结构与技术规格】
文件数 7 个,合计 234.00 KB。pone.0205924.s001.docx:application/vnd.openxmlformats-officedocument.wordprocessingml.document,20.36 KB。pone.0205924.s002.docx:application/vnd.openxmlformats-officedocument.wordprocessingml.document,22.48 KB。pone.0205924.s003.docx:application/vnd.openxmlformats-officedocument.wordprocessingml.document,22.06 KB。数据集 DOI:10.1371/journal.pone.0205924。
【主题与分类】
源站学科分类:Medicine、Cell Biology、Biotechnology、Immunology、Developmental Biology、Infectious Diseases。主题标签:Patients Refined Diagnosis-Related Group code、hospital costs、sepsis biomarker use、CRP、PCT、Premier Healthcare Database hospitals、study Background Sepsis management guidelines、patient outcomes、Serial biomarker monitoring、adult sepsis discharges。
【适用方向】
结构化表格数据可直接用于统计建模、特征工程与队列分析。
【获取与许可】
源站页面:https://plos.figshare.com/articles/dataset/Real-world_use_of_procalcitonin_and_other_biomarkers_among_sepsis_hospitalizations_in_the_United_States_A_retrospective_observational_study/7221074
使用许可:CC BY 4.0(https://creativecommons.org/licenses/by/4.0/)。
规范引用:Gluck, Eric; Bryant Nguyen, H.; Yalamanchili, Kishore; McCusker, Margaret; Madala, Jaya; Corvino, Frank A.; et al. (2018). Real-world use of procalcitonin and other biomarkers among sepsis hospitalizations in the United States: A retrospective, observational study. PLOS ONE. Dataset
【使用注意】
· 源站最后修改于 2023-06-01,引用时请注意版本时效。
下载信息
注册下载
需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。
暂未开放公开下载
无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。
免登录有偿下载
公开数据集受托下载与技术交付服务。
提供高速下载与技术交付服务(收技术服务费,非数据销售)
暂未开放当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。
使用方式
数据集获取(Figshare)
- 源站标题:Real-world use of procalcitonin and other biomarkers among sepsis hospitalizations in the United States: A retrospective, observational study
- DOI:10.1371/journal.pone.0205924
- 发布日期:2018-10-17
- 文件数:7 个
- 文件总体积:234.00 KB
- 源站页面:https://plos.figshare.com/articles/dataset/Real-world_use_of_procalcitonin_and_other_biomarkers_among_sepsis_hospitalizations_in_the_United_States_A_retrospective_observational_study/7221074
命令行下载
curl -L -o "pone.0205924.s001.docx" "https://ndownloader.figshare.com/files/13296647"
curl -L -o "pone.0205924.s002.docx" "https://ndownloader.figshare.com/files/13296650"
curl -L -o "pone.0205924.s003.docx" "https://ndownloader.figshare.com/files/13296653"
curl -L -o "pone.0205924.s004.docx" "https://ndownloader.figshare.com/files/13296656"
curl -L -o "pone.0205924.s005.docx" "https://ndownloader.figshare.com/files/13296659"
curl -L -o "pone.0205924.s006.docx" "https://ndownloader.figshare.com/files/13296662"
curl -L -o "pone.0205924.s007.pdf" "https://ndownloader.figshare.com/files/13296665"
文件清单
pone.0205924.s001.docx(20.36 KB)pone.0205924.s002.docx(22.48 KB)pone.0205924.s003.docx(22.06 KB)pone.0205924.s004.docx(21.61 KB)pone.0205924.s005.docx(22.81 KB)pone.0205924.s006.docx(21.15 KB)pone.0205924.s007.pdf(103.53 KB)
文件总体积 234.00 KB(源站 API 实测)。
数据加载示例(图像类)
from PIL import Image
import glob, os
files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)
# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path) # 要求 子目录=类别
目录组织与标注格式以源站说明和下载后实际文件为准。
数据说明
Background
Sepsis management guidelines endorse use of biomarkers to support clinical assessment and treatment decisions in septic patients. The impact of biomarkers on improving patient outcomes remains uncertain.
Methods
Retrospective observational study of adult sepsis discharges between January 1, 2012, and December 31, 2015, from Premier Healthcare Database hospitals. Sepsis was defined by an All Patients Refined Diagnosis-Related Group code of 720 (septicemia and disseminated infections). Use of four biomarker strategies was evaluated based on hospital records: (i) >1 procalcitonin (PCT), (ii) 1 PCT, (iii) no PCT but ≥1 C-reactive protein (CRP) and/or lactate and (iv) no sepsis biomarkers. Associations between biomarker use and clinical and cost outcomes were examined. The primary outcome was impact of biomarker strategy on hospital costs per day.
Results
Among 933,591 adult sepsis discharges during the study period, 731,392 (78%) had biomarker tests ordered. In multivariable analyses, discharges with >1 PCT had higher hospital costs per day ($1,904; 95% confidence interval [CI] $1,896–$1,911) compared with discharges with no sepsis biomarkers ($1,606; 95% CI $1,658–$1,664). Discharges with >1 PCT also had greater illness severity and antimicrobial exposure compared with other biomarker-use groups. The adjusted odds of dying during hospital stay compared with being discharged were significantly lower for sepsis discharges with >1 PCT (0.64; 95% CI 0.61–0.67) and 1 PCT (0.88; 95% CI 0.85–0.91) compared with no sepsis biomarker use. The proportion of discharges with ≥1 PCT increased almost six-fold during the study; use of other biomarkers remained constant.
Conclusions
Between 2012 and 2015, PCT use among sepsis discharges increased six-fold while lactate and CRP use remained unchanged. PCT use was associated with decreased odds of in-hospital mortality but increased hospital costs per day. Serial biomarker monitoring may be associated with improved patient outcomes in the most critically ill septic patients.
许可
CC BY 4.0
引用
学术使用请引用 DOI 10.1371/journal.pone.0205924(source: https://plos.figshare.com/articles/dataset/Real-world_use_of_procalcitonin_and_other_biomarkers_among_sepsis_hospitalizations_in_the_United_States_A_retrospective_observational_study/7221074)。
数据缺失?
依托陕西、四川两大基地,我们与超过十家三甲医院建立直接合作关系,覆盖合规授权、采集治理、专业标注、数据交付的全流程,为AI医疗团队提供即拿即用的高质量临床数据。
⚡️ 需要数据支持或标注服务?立即联系我们获取专业方案。




